풀크럼 테라퓨틱스(FULC)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $3.76 (-0.27%), 시가총액 $490.42M.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders.
풀크럼 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
풀크럼 테라퓨틱스의 현재 주가는 $3.76 (-0.27%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
풀크럼 테라퓨틱스의 시가총액은 약 $490.42M입니다.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical…